The Effect of Canagliflozin Dose on Renal and Cardiovascular Outcomes in Type 2 Diabetes and High Cardiovascular Risk Citation: Elenjickal EJ, Baroz F, Boileau P, et al. Diabetes Obes Metab. 2026 May 31. Epub ahead of print. PMID: 42219264.
The YODA Project